Limited human clinical evidence for some peptides, which complicates the evaluation of their safety and effectiveness
According to the Lilly statement, this discovery is concerning because nothing is known about the short- or long-term effects of this molecule in humans, or whether there are any potential impacts on the drugs efficacy, toxicity, or immune reactions
This medication might make you sleepy eventually making you sleepy at times
Chronic conditions may warrant longer use under specialist supervision, with periodic reassessment of whether the combination is still contributing
Side Effects and Safety Concerns with BPC-157 Clinical side effect data for BPC-157 remains extremely limited
[20] Treatment of megaloblastic anemia with concurrent vitamin B 12 deficiency using B 12 vitamers (including cyanocobalamin), creates the possibility of hypokalemia due to increased erythropoiesis (red blood cell production) and consequent cellular uptake of potassium upon anemia resolution